The global coagulation factor deficiency treatment market is witnessing significant growth due to growing prevalence of hemophilia and other bleeding disorders. Progresses within the industry are driving demand for superior treatment options. The market is segmented by product type, indication, distribution channel, with rapid expansion in the Uni